Multimorbidity in the ageing human brain: lessons from neuropathological assessmentKirsty McAleese · Newcastle University8 Jun
Cholinergic system and amyloid beta (Aβ) interplay at tripartite glutamatergic synapses in an alternative mouse model of Alzheimer’s diseaseManuela Tore, Nicole Tonesi, Irene Incerti et al.
Functional analysis of spontaneous neuronal activity in cortical organoids as a model of human tauopathiesKarolina Zimkowska, Marc Riu-Villanueva, Amayra Hernández-Vega et al.
An IgLON5 knockout mouse model results in mild behavioral alterations, without neurodegenerationAna Beatriz Serafim, Jon Landa, Mercedes Alba et al.
Investigating a new tau aggregation inhibitor “RE01” in PS19 transgenic miceDilek Mercan, Arush Baijal, Fabrizio Musacchio et al.
Investigating the therapeutic potential of metformin in ameliorating tau pathology in a cellular model of Alzheimer’s diseaseSrinithya Paruchuri, Shreyasi Chatterjee
Irisin levels in cerebrospinal fluid correlate with biomarkers and clinical dementia scores in Alzheimer’s diseaseManuela Dicarlo, Patrizia Pignataro, Chiara Zecca et al.
Selective detection of neurofibrillary tangles (NFTs) in iPSC-derived retinal cells and postmortem samples of Alzheimer's disease patients’ retina by a novel BODIPY-fluorescent ligandYlenia Gigante
SGLT2 and DPP4 inhibitors improve Alzheimer’s disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse modelA Young Sim, Jong Youl Kim, Yong-ho Lee, Jong Eun Lee
Using photopharmacology as a tool to study mGlu5 hippocampal asymmetry in AD miceCharleine Zussy, Mathieu Vitalis, Magalie Mathias et al.